Vicharchika, a chronic inflammatory skin disorder categorized under Kustha Roga in Ayurveda, closely resembles eczema in modern dermatology and presents with symptoms such as itching, oozing, discoloration, and skin thickening. The condition arises from the vitiation of Kapha, Pitta, and Rakta Dhatu, necessitating therapies that target blood purification and dosha balance. Manjistha Kwath, a classical decoction derived from Rubia cordifolia Linn., is traditionally acclaimed for its potent Raktashodhaka (blood-purifying) and Kushtaghna (anti-skin disease) properties. This review critically examines both classical Ayurvedic texts and contemporary pharmacological studies to elucidate the therapeutic potential of Manjistha Kwath in managing Vicharchika. The formulation’s bitter-astringent taste, hot potency, and pungent post-digestive effect support the pacification of Pitta and Kapha doshas. Modern research highlights its significant anti-inflammatory, antioxidant, antimicrobial, hepatoprotective, and immunomodulatory activities. Clinical evidence demonstrates marked improvement in symptoms such as itching, oozing, and pigmentation following 4–6 weeks of treatment, with a favorable safety profile. These findings substantiate the role of Manjistha Kwath as a safe, effective, and holistic intervention for chronic eczematous skin disorders, bridging traditional wisdom with scientific validation.
Sharman et al. (Tue,) studied this question.